Warburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reports

A consortium consisting of Warburg Pincus and KKR (KKR.N), opens new tab is in talks to acquire German packaging and medical equipment maker Gerresheimer AG (GXIG.DE), opens new tab, Bloomberg News reported on Wednesday, citing people familiar with the matter.

The private equity firms have emerged as the frontrunner after they teamed up and other potential bidders including Bain Capital dropped out, Bloomberg News said.

Gerresheimer, which makes pens used to inject weight loss drugs such as Novo Nordisk's (NOVOb.CO), opens new tab Wegovy, has a market capitalization of about 2.74 billion euros ($2.99 billion), according to LSEG data.

Warburg Pincus, KKR and Gerresheimer declined to comment on the report.
In February, the company confirmed it was in early-stage discussions with private equity investors over a potential sale of the company.

Gerresheimer also halved its revenue guidance for 2025 over weakness in its cosmetics and food and beverage segments and now expects organic revenue growth in the range of 3% to 5% in 2025, down from the previous range of 7% to 10%.

(Source: ISPE)